Eisai And Biogen: Only APOE4 Carriers Benefit From Lecanemab For Alzheimer's Disease
Seeking Alpha,
Once again, Eisai (OTCPK:ESALY) and Biogen (BIIB) are touting success for an anti-amyloid drug that has limited efficacy…
Once again, Eisai (OTCPK:ESALY) and Biogen (BIIB) are touting success for an anti-amyloid drug that has limited efficacy…
More bad news for Alzheimer’s research. Two more BACE inhibitors fall far short of the finish line.
(Source: Mayo Foundation for Medical Education and Research) Tuesday Q and A: Many conditions result in dementia, but Alzheimer's…